Filing Impact
Filing Sentiment
Form Type
144
Kala Pharmaceuticals Inc
Jan 8, 2026
[8-K] KALA BIO, Inc. Reports Material Event
Dec 16, 2025
[8-K] KALA BIO, Inc. Reports Material Event
Dec 16, 2025
[8-K] KALA BIO, Inc. Reports Material Event
18.80M
8.10M
1.75%
51.86%
5.98%
Biotechnology
Pharmaceutical Preparations
United States
ARLINGTON